Tonix Pharmaceuticals Holding (TNXP) Free Cash Flow (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Free Cash Flow of -$44.0 million for Q1 2026, down 165.36% year-over-year from $67.3 million in Q1 2025, and down 5.99% quarter-over-quarter from -$41.5 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Free Cash Flow (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$44.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 165.36% year-over-year to -$44.0 million; the TTM figure through Mar 2026 stood at -$130.6 million (down 117.92% YoY), while the FY2025 annual figure was -$103.2 million, down 69.08% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$44.0 million, down from -$41.5 million in the prior quarter.
- The five-year high for Free Cash Flow was -$9.9 million in Q2 2024, with the low at -$51.3 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$27.0 million (2022), against an average of -$27.3 million.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow surged 58.96% in 2024, then sank 183.77% in 2025.
- Tonix Pharmaceuticals Holding's Free Cash Flow stood at -$27.0 million in 2022, then dropped by 11.08% to -$30.0 million in 2023, then surged by 51.16% to -$14.6 million in 2024, then tumbled by 183.77% to -$41.5 million in 2025, then fell by 5.99% to -$44.0 million in 2026.
- Business Quant data shows TNXP's Free Cash Flow at -$44.0 million in Q1 2026, -$41.5 million in Q4 2025, and -$29.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -40.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.78 Mn |
| Jun 30, 2026 | -40.78 Mn |
| Mar 31, 2026 | -44.01 Mn |
| Mar 31, 2026 | -44.01 Mn |
| Dec 31, 2025 | -41.52 Mn |
| Dec 31, 2025 | -41.52 Mn |
| Sep 30, 2025 | -29.75 Mn |
| Sep 30, 2025 | -29.75 Mn |
| Jun 30, 2025 | -15.35 Mn |
| Jun 30, 2025 | -15.35 Mn |
| Mar 31, 2025 | -16.59 Mn |
| Mar 31, 2025 | -16.59 Mn |
| Dec 31, 2024 | -14.63 Mn |
| Dec 31, 2024 | -14.63 Mn |
| Sep 30, 2024 | -18.81 Mn |
| Sep 30, 2024 | -18.81 Mn |
| Jun 30, 2024 | -9.92 Mn |
| Jun 30, 2024 | -9.92 Mn |
| Mar 31, 2024 | -17.68 Mn |
| Mar 31, 2024 | -17.68 Mn |